The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.
![]() ![]() | Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5 ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (30 May 2023). Urolithin A and B accelerate myocyte fusion into myotubes. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1926-1927. doi:10.1136/annrheumdis-2023-eular.3536 ![]() |
![]() ![]() | Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (30 May 2023). Osteomodulin down-regulation is associated with osteoarthritis development. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1194-1195. doi:10.1136/annrheumdis-2023-eular.1006 ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (March 2023). Deciphering Urolithins A And B Activities On Muscle: Transcriptomic Modulation On Human Primary Myotubes. Osteoarthritis and Cartilage, 31, 303. doi:10.1016/j.joca.2023.01.316 ![]() |
![]() ![]() | Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (March 2023). Osteomodulin Is Involved In Bone And Cartilage Homeostasis And Osteoarthritis Development. Osteoarthritis and Cartilage, 31, 323-S324. doi:10.1016/j.joca.2023.01.350 ![]() |
![]() ![]() | Uebelhoer, M., Lambert, C., Grisart, J., Guse, K., Plutizki, S., & Henrotin, Y. (2023). Interleukins, growth factors, and transcription factors are key targets for gene therapy in osteoarthritis: A scoping review. Frontiers in Medicine, 10, 1148623. doi:10.3389/fmed.2023.1148623 ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (December 2022). Évaluation de l’activité des urolithines A et B sur le muscle : modulation transcriptomique sur les myotubes primaires humains. Revue du Rhumatisme, 89, 49-A50. doi:10.1016/j.rhum.2022.10.061 ![]() |
![]() ![]() | Zappia, J., Van Der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Lories, R., Elewaut, D., Sanchez, C., & Henrotin, Y. (December 2022). L’ostéomoduline joue un rôle majeur dans l’homéostasie de l’os et du cartilage. Revue du Rhumatisme, 89, 176. doi:10.1016/j.rhum.2022.10.261 ![]() |
![]() ![]() | Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914 ![]() |
![]() ![]() | Sanchez, C., Zappia, J., Lambert, C., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., & Henrotin, Y. (April 2022). CURCUMA LONGA AND BOSWELLIA SERRATA EXTRACTS MODULATE DIFFERENT AND COMPLEMENTARY PATHWAYS TO EXERT ANTI-INFLAMMATORY, ANTI-OXIDATIVE AND ANTI-CATABOLIC ACTIVITIES ON CHONDROCYTES: DECIPHERING OF A TRANSCRIPTOMIC STUDY. Osteoarthritis and Cartilage, 30 (Suppl 1), 435. doi:10.1016/j.joca.2022.02.589 ![]() |
![]() ![]() | Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855 ![]() |
![]() ![]() | Sanchez, C., Lambert, C., Zappia, J., Dubuc, J.-E., Delcour, J.-P., Dierckxsens, Y., & Henrotin, Y. (December 2021). Les extraits de Curcuma longa et de Boswellia serrata agissent par des mécanismes différents et complémentaires pour exercer une action anti-inflammatoire, anti-oxidante et anti-catabolique sur les chondrocytes : déchiffrage d’une étude transcriptomique. Revue du Rhumatisme, 88 (S1), 154. doi:10.1016/j.rhum.2021.10.242 ![]() |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (April 2021). Development of a primary skeletal muscle cell culture model from human muscle biopsies. Osteoarthritis and Cartilage, 29 (Suppl), 108. ![]() |
![]() ![]() | Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin impacts positively the bone remodeling process in osteoarthritis. Osteoarthritis and Cartilage, 29 (Suppl 1), 111. doi:10.1016/j.joca.2021.02.155 ![]() |
![]() ![]() | Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin Impacts Positively The Bone Remodeling Process In Osteoarthritis. Bone Reports, 14 (Suppl 1), 2352-1872. doi:10.1016/j.bonr.2021.100904 ![]() |
![]() ![]() | Lambert, C., Bellemère, G., Boyer, G., Ponelle, F., Bauer, T., Legeny, M.-C., Baudouin, C., & Henrotin, Y. (2021). Composition Analysis and Pharmacological Activity of Avocado/Soybean Unsaponifiable Products Used in the Treatment of Osteoarthritis. Frontiers in Pharmacology, 12, 781389. doi:10.3389/fphar.2021.781389 ![]() |
![]() ![]() | Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186 ![]() |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (December 2020). Mise au point d’un modèle de culture original de cellules musculaires squelettiques à partir de biopsies musculaires humaines. Revue du Rhumatisme, Volume 87 (Supplément 1). doi:10.1016/j.rhum.2020.10.433 ![]() |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019 ![]() |
![]() ![]() | Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080 ![]() |
![]() ![]() | Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (07 October 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes [Paper presentation]. 15th World Congress of ICRS, Vancouver, Canada. |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (02 October 2019). Development of a muscle cell culture model from human muscle biopsies [Poster presentation]. EORS 2019, Maastricht, Netherlands. |
![]() ![]() | Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (June 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Annals of the Rheumatic Diseases, 78 (Suppl 2), 1508. ![]() |
Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (03 May 2019). A systematic review of the secretome of skeletal muscle cells [Poster presentation]. Osteoarthritis Research Society International 2019, Toronto, Canada. doi:10.1016/j.joca.2019.02.677 |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Durieux, N., Mobasheri, A., & Henrotin, Y. (04 April 2019). Sécrétome des cellules musculaires squelettiques: revue systématique de la littérature [Paper presentation]. Congrès Fragilité du sujet âgé, Paris, France. |
![]() ![]() | Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (April 2019). Syndecan-4 is increased in osteoarthritic knee, but nor ip or shoulder, articular hypertrophic chondrocytes. Osteoarthritis and Cartilage, 27 (Suppl 1), 159-160. ![]() |
![]() ![]() | Florin, A., Lambert, C., Sanchez, C., Mobasheri, A., & Henrotin, Y. (20 February 2019). The secretome of skeletal muscle cells: A systematic review [Poster presentation]. International Conference on Frailty & Sarcopenia Research, Miami, United States. |
![]() ![]() | Lambert, C., Borderie, D., Dubuc, J.-E., Rannou, F., & Henrotin, Y. (2019). Type II collagen peptide Coll2-1 is an actor of synovitis. Osteoarthritis and Cartilage, 27 (11), 1680-1691. doi:10.1016/j.joca.2019.07.009 ![]() |
![]() ![]() | Mobasheri, A., Lambert, C., & Henrotin, Y. (2019). Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover–biomarkers to facilitate the treatment of osteoarthritis? Expert Review of Molecular Diagnostics, 19 (9), 803-812. doi:10.1080/14737159.2019.1646641 ![]() |
![]() ![]() | Sanchez, C., Lambert, C., Dubuc, J., Bertrand, J., Pap, T., & Henrotin, Y. (November 2018). Le syndécan-4 est un marqueur de l’hypertrophie des chondrocytes du genou arthrosique. Revue du Rhumatisme, 85S, 327. ![]() |
![]() ![]() | Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (June 2018). THE COLL2–1 PEPTIDE OF COLLAGEN TYPE II: A NEW ACTOR OF SYNOVITIS IN OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 890. ![]() |
![]() ![]() | Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Lambert, C., Davidson, R. K., Clark, I. M., Thornalley, P. J., Henrotin, Y., & Rabbani, N. (June 2018). Glycation marker glucosepane increases with the progression of osteoarthritis and correlates with morphological and functional changes of cartilage in vivo. Arthritis Research and Therapy, 20 (1), 131. doi:10.1186/s13075-018-1636-6 ![]() |
![]() ![]() | Sanchez, C., Mazzucchelli, G., Comblain, F., Lambert, C., De Pauw, E., & Henrotin, Y. (June 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Annals of the Rheumatic Diseases, 77 (supplement 2), 894. ![]() |
![]() ![]() | Rabbani, N., Ahmed, U., Lambert, C., Legrand, C., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., & Henrotin, Y. (June 2018). GLUCOSEPANE : A NEW BIOMARKER OF THE SEVERITY OF OSTEOARTHRITIS. Annals of the Rheumatic Diseases, 77 (supplement 2), 181. ![]() |
![]() ![]() | Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (April 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Osteoarthritis and Cartilage, 26 (supplement 1), 89. doi:10.1016/j.joca.2018.02.192 ![]() |
![]() ![]() | Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591 ![]() |
![]() ![]() | Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (December 2017). L’analyse protéomique du sécrétome des ostéoblastes fournis de nouvelles indications sur les mécanismes de la sclérose sous-chondrale dans l’arthrose. Revue du Rhumatisme, 84 (S1), 295. ![]() |
![]() ![]() | Comblain, F., Lambert, C., Sanchez, C., Dubuc, J.-E., Barthélémy, N., Lefebvre, M., Schwartz, C., Lesponne, I., Serisier, S., Feugier, A., Balligand, M., & Henrotin, Y. (May 2017). In vitro and clinical studies of a new nutraceuticals mixture for the management of osteoarthritis [Poster presentation]. Young Researchers in Life Sciences, Paris, France. |
![]() ![]() | Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (27 April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. OARSI World Congress on Osteoarthritis, Caesar's Palace Las Vegas, United States. |
![]() ![]() | Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs. Osteoarthritis and Cartilage, 25, 314-s315. ![]() |
![]() ![]() | Lambert, C., Borderie, D., Rannou, F., & Henrotin, Y. (2017). Le peptide Coll2-1 du collagène de type II : un nouvel acteur de la synovite dans l’arthrose. Revue du Rhumatisme, 84S, 50. ![]() |
![]() ![]() | Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (2017). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Cartilage, 1-23. doi:10.1177/1947603516656739 ![]() |
![]() ![]() | Lambert, C., Legrand, C., Ahmed, U., Anwar, A., Rajpoot, K., Pasha, S., Davidson, R., Clark, I., Thornalley, P., Rabbani, N., & Henrotin, Y. (2017). Le glucosépane : un nouveau marqueur de la sévérité de l’arthrose. Revue du Rhumatisme, 84S, 102. ![]() |
![]() ![]() | Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (16 November 2016). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs [Poster presentation]. Bioforum Proceedings 2016, Liège, Belgium. |
![]() ![]() | Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (November 2016). Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley. Revue du Rhumatisme, 83S, 209-A210. doi:10.1016/S1169-8330(16)30512-9 ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., Borderie, D., & Rannou, F. (23 June 2016). Coll2-1 peptide and its nitrated form as therapeutic targets for osteoarthritis treatment. |
![]() ![]() | Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902 ![]() |
![]() ![]() | Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (April 2016). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Osteoarthritis and Cartilage, 24 (Supp 1), 353. ![]() |
![]() ![]() | Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (April 2016). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Osteoarthritis and Cartilage, 24 (suppl 1), 88. ![]() |
![]() ![]() | Sanchez, C., Lambert, C., Comblain, F., Legrand, C., & Henrotin, Y. (April 2016). Osteoarthritic sclerotic subchondral osteoblasts secreted elevated concentration of fibulin-3 fragments in vitro. Osteoarthritis and Cartilage, 24 (suppl 1), 83. ![]() |
![]() ![]() | Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification d’un spectre de cibles thérapeutiques d’un nouveau traitement pour l’arthrose composé d’extrait de curcuminoïdes, de collagène hydrolysé et d’extrait de thé vert. Revue du Rhumatisme. ![]() |
![]() ![]() | Comblain, F., Lambert, C., Lesponne, I., Sanchez, C., Dubuc, J.-E., & Henrotin, Y. (2015). Identification of a Spectrum of Therapeutic Targets of a New Treatment for Osteoarthritis Composed By Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. Arthritis and Rheumatology, 67 (Suppl10). ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., & Richette, P. (April 2014). Importance of synovitis in osteoarthritis: Evidence for the use of glycosaminoglycans against synovial inflammation. Seminars in Arthritis and Rheumatism, 43 (5), 579-87. doi:10.1016/j.semarthrit.2013.10.005 ![]() |
![]() ![]() | Henrotin, Y., Pesesse, L., & Lambert, C. (February 2014). Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Therapeutic Advances in Musculoskeletal Disease, 6 (1), 20-34. doi:10.1177/1759720X13514669 ![]() |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Verges, J., Munaut, C., Noël, A., & Henrotin, Y. (2014). Gene expression pattern of synovial cells from inflammatory and normal areas of osteoarthritis synovial membrane. Arthritis and Rheumatism, sous presse. doi:10.1002/art.38315 ![]() |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN THE INFLAMED SYNOVIAL MEMBRANE [Paper presentation]. BMJD 2013, Brussels, Belgium. |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (23 November 2013). EFFECTS OF CHONDROITIN SULFATE ON THE GENE EXPRESSION PROFILE IN INTERLEUKIN-1Β STIMULATED SYNOVIAL FIBROBLAST CELLS CULTURES [Paper presentation]. BMJD 2013, Brussels, Belgium. |
![]() ![]() | Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (November 2013). SYNERGISTIC BENEFICIAL EFFECTS OF CURCUMA EXTRACT, GREEN TEA EXTRACT AND HYDROLYZED COLLAGEN IN BOVINE CHONDROCYTES IN MONOLAYER CULTURE [Poster presentation]. Bone, Muscle & Joint Diseases 2013, Brussels, Belgium. |
![]() ![]() | Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (02 October 2013). Synergistic beneficial effects of curcuma extract, green tea extract and hydrolysed collagen in bovine chondrocytes in monolayer culture [Paper presentation]. Waltham International Nutritional Sciences Symposium 2013, Portland, United States - Oregon. |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in the inflamed synovial membrane. Osteoarthritis and Cartilage, 21 (Supplement April 2013). ![]() |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., & Henrotin, Y. (April 2013). Effects of chondroitin sulfate on the gene expression profile in IL-1β stimulated synovial fibroblast cells cultures. Osteoarthritis and Cartilage, 21 (Supplement April 2013). ![]() |
![]() ![]() | Lambert, C., Dubuc, J.-E., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (April 2013). Investigation of potential new targets for the diagnosis and/or the treatment of osteoarthritis. Osteoarthritis and Cartilage, 21 (Supplement April 2013). ![]() |
![]() ![]() | Vandenbosch, R., Chocholova, E., Robe, P., Wang, Y., Lambert, C., Moonen, G., Lallemend, F., Malgrange, B., & Hadjab, S. (2013). A role for the canonical nuclear factor-κB pathway in coupling neurotrophin-induced differential survival of developing spiral ganglion neurons. Frontiers in Cellular Neuroscience, 7, 1-10. doi:10.3389/fncel.2013.00242 ![]() |
![]() ![]() | Comblain, F., Sanchez, C., Lambert, C., Serisier, S., & Henrotin, Y. (2013). Effets bénéfiques et synergiques du curcuma, du thé vert et du collagène hydrolysé sur des chondrocytes bovins cultivés en monocouche. Revue du Rhumatisme, 80S, 130. ![]() |
![]() ![]() | Henrotin, Y., & Lambert, C. (2013). Chondroitin and glucosamine in the management of osteoarthritis: an update. Current Rheumatology Reports. doi:10.1007/s11926-013-0361-z ![]() |
![]() ![]() | Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (17 July 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates [Poster presentation]. 6th European congress of pharmacology, Granada, Spain. |
![]() ![]() | Lambert, C., Dubuc, J.-E., & Henrotin, Y. (19 April 2012). An original methodology to study the synovial tissue in OA patient [Poster presentation]. Biomedica, Liège, Belgium. |
![]() ![]() | Lambert, C., Dubuc, J.-E., Hennuy, B., Montell, E., Vergés, J., & Henrotin, Y. (April 2012). Expression of specific pathways in the inflamed synovial membrane of osteoarthritis patient: Identification of new potential key intermediates. Osteoarthritis and Cartilage, 20 (Supplement 1), 56. ![]() |
![]() ![]() | Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. (March 2012). Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research and Therapy, 14 (2), 58. doi:10.1186/ar3771 ![]() |
![]() ![]() | Henrotin, Y., Lambert, C., Couchourel, D., Ripoll, C., & Chiotelli, E. (2011). Nutraceuticals: do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis and Cartilage, 19 (1), 1-21. doi:10.1016/j.joca.2010.10.017 ![]() |
![]() ![]() | Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (October 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate. Osteoarthritis and Cartilage, 18, 45-S46. doi:10.1016/S1063-4584(10)60113-6 ![]() |
![]() ![]() | Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). Synovium angiogenesis in osteoarthritis: a new therapy target for chondroitin sulfate [Poster presentation]. 2010 World Congress on Osteoarthritis, Bruxelles, Belgium. |
![]() ![]() | Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (September 2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule [Poster presentation]. 23e congrès français de rhumatologie, Paris, France. |
![]() ![]() | Mathy, M., Lambert, C., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). La chondroitine sulfate stimule la production des facteurs anti angiogéniques TSP-1 et VEGI par les synoviocytes arthrosiques : un nouveau mécanisme d’action pour cette molécule. Revue du Rhumatisme, 77, 251-A252. ![]() |
![]() ![]() | Lambert, C., Mathy, M., Dubuc, J. E., Montell, E., Vergés, J., & Henrotin, Y. (2010). Etude du phenotype des synoviocytes fibroblast-like isolés à partir de tissu synovial arthrosique. Revue du Rhumatisme, 77, 105. ![]() |
![]() ![]() | Henrotin, Y., Mathy, M., Sanchez, C., & Lambert, C. (2010). Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. Therapeutic Advances in Musculoskeletal Disease, 2 (6), 335-348. doi:10.1177/1759720X10383076 ![]() |
![]() ![]() | Mathy, M., Jacquemond-Collet, I., Priem, F., Sanchez, C., Lambert, C., & Henrotin, Y. (December 2009). Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflammation Research, 58, 899-908. doi:10.1007/s00011-009-0063-1 ![]() |
Lambert, C. (2008). Régulation de l'expression du gène de l'ostéoprotégérine dans les cellules ostéosarcomateuses MG-63 [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/56850 |
![]() ![]() | Lambert, C., Oury, C., Dejardin, E., Chariot, A., Piette, J., Malaise, M., Merville, M.-P., & Franchimont, N. (September 2007). Further insights in the mechanisms of interleukin-1beta stimulation of osteoprotegerin in osteoblast-like cells. Journal of Bone and Mineral Research, 22 (9), 1350-1361. doi:10.1359/jbmr.070508 ![]() |
![]() ![]() | Fischer, A., Karasi, J. C., Kibibi, D., Omes, C., Lambert, C., Uwayitu, A., Hemmer, R., Ende, J., Schmit, J.-C., & Arendt, V. (2006). Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002. HIV Medicine, 7 (1), 64-6. doi:10.1111/j.1468-1293.2005.00338.x ![]() |
![]() ![]() | Franchimont, N., Lambert, C., Huynen, P., Ribbens, C., Relic, B., Chariot, A., Bours, V., Piette, J., Merville, M.-P., & Malaise, M. (2005). Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis and Rheumatism, 52 (1), 84-93. doi:10.1002/art.20727 ![]() |